By Stuart Kurtz, M.S. D-ABFT-FT The purpose of these next two blog posts is to discuss the utility that vitreous humor provides in the context of a case. This first post will focus on what vitreous humor is and the caveats associated with its interpretation. The...
By Denise Purdie Andrews Recent industry news has been consumed with xylazine as the latest drug adulterant on the streets. Axis, your leading toxicology partner, has been testing for xylazine for several years and is prepared to assist you with questions about it...
The purpose of this blog post is to take a look at some of our data regarding nitazene detections. For some background on nitazene compounds, take a look at our blog post of June 9, 2022 titled Drug Primer: Nitazenes. As a reminder, nitazenes are a structurally...
Kevin Shanks presented on Fluorofentanyl at the Society of Forensic Toxicologists (SOFT) annual meeting in Cleveland, OH. The title of the talk is below and the abstract is available upon request. Fluorofentanyl Detection by LC-QToFMS & Prevalence in Postmortem...
Dear Valued Client, In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in...
In October, toxicologist Stuart Kurtz presented a poster at the annual National Association of Medical Examiners (NAME) meeting in Dallas, TX. The abstract is below. A Case Report Involving the Detection of Five New Psychoactive Substances in Postmortem Analysis. ...
Dr. George Behonick presented the following poster at the annual NAME meeting in Dallas, TX. This is the first of several articles to share recent presentations by our toxicologists. Postmortem Redistribution of Fentanyl as Evidenced by Central and Peripheral Blood...
By Denise Purdie Andrews This Fall, Axis’ expert toxicologists can be found speaking in several different venues, helping to educate our clients and share expertise with other forensic scientists. Last month, George S. Behonick, PhD, presented at the Indiana...
Dear Valued Client, In the spirit of continual improvement and to provide our clients with industry leading service, we are excited to announce an upcoming change in testing associated with our 42130: Synthetic Cannabinoids Panel. While these types of compounds have...
